MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

    I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)

    Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
  • 2024 International Congress

    Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis.

    A-M. Hanff, C. Mccrum, A. Rauschenberger, S. Pachchek, G. Aguayo, C. Pauly, S. Jónsdóttir, O. Tsurkalenko, L. Pauly, Z. Landoulsi, A. Leist, P. May, M. Zeegers, R. Krüger (Strassen, Luxembourg)

    Objective: To compare progression of motor- and non-motor symptoms in people with Parkinson’s disease (PD) with Gaucher-related gene glucocerebrosidase (GBA1) variants compared to people with…
  • 2024 International Congress

    Eye movements and cognitive function

    A. Ovchynnykova, Y. Trufanov, M. Trishchynska (Kyiv, Ukraine)

    Objective: find out the relationship between eye movements and cognitive function (CF). Background: working in our clinic we have learned to give a pre-assessment of…
  • 2024 International Congress

    Cognitive Performance in Early Neuronal alpha-Synuclein Disease

    D. Weintraub, M. Brumm, A. Nair, M. York, R. Dobkin, K. Marek, C. Tanner, T. Simuni, A. Siderowf, D. Galasko, L. Chahine, C. Coffey, K. Merchant, K. Poston, T. Foroud, B. Mollenhauer, E. Brown, K. Kieburtz, M. Frasier, T. Sherer, S. Chowdhury, R. Alcalay, A. Videnovic (Ardmore, USA)

    Objective: To determine if cognitive deficits can be detected in early-stage Neuronal alpha-Synuclein Disease (NSD) compared with healthy controls. Background: Global cognitive deficits have been…
  • 2024 International Congress

    Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder

    S. Khudayarova, G. Rakhmatullayeva (Tashkent, Uzbekistan)

    Objective: To study the effect of cystatin C on the development of cognitive disorders(CD) in patients with CKD(Chronic kidney disease) and vascular parkinsonism Background: Clinical…
  • 2024 International Congress

    Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms

    S. Messner, T. Carmody, R. Park, B. Jones, A. Hursey, E. Lucassen (Basel, Switzerland)

    Objective: To assess the most common, burdensome and worrisome symptoms experienced by people living with early Parkinson’s Disease (ePD). Background: Research on symptom frequency and…
  • 2024 International Congress

    The effects of DL-3-n-butylphthalide in patients with mild cognitive impairment due to Parkinson’s disease: A multicenter, randomized, double-blind, placebo-controlled trial

    C. Han, Y. Xia, J. Wu, Y. Sun, L. Kou, J. Huang, Q. Wang, E. Xu, H. Yu, Q. Ye, X. Luo, H. Ma, H. Chen, L. Wang, T. Wang (wuhan, China)

    Objective: To assess the therapeutic effect of DL-3-n-butylphthalide on cognitive impairment associated with Parkinson’s disease (PD). Background: PD associated cognitive impairment are attracting attention because…
  • 2024 International Congress

    Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene

    J. Böhm, J. Uter, R. Lundin, J. Henkel, P. Pramstaller, C. Klein, A. Hicks, M. Heldmann, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating heterozygous Parkin gene (PRKN) mutation carriers to evaluate the potential association of this mutation with an alteration of cognitive control processes. Background: Recessively…
  • 2024 International Congress

    Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study

    YM. Sun, C. Chen, XY. Zhou, FT. Liu, JJ. Wu, J. Wang (Shanghai, China)

    Objective: To investigate disease progression of PLA2G6-related parkinsonism in a longitudinal study. Background: There is a paucity of follow-up studies on disease progression in PLA2G6-related…
  • 2024 International Congress

    The course of cognitive impairment in Parkinson’s disease patients with Сovid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: A comparative analysis of the characteristics of cognitive impairment in Parkinson's disease patients with and without Сovid-19. Background: Covid-19 infection strongly affects the central…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley